To assess the tumor-specific T cell responses triggered by gas nanoadjuvant-assisted photoimmunotherapy, the percentage of gp70 tetramer-specific CD8+ T cells in the spleen was monitored by flow cytometry analysis. This evidence concerns the gene CD8A and neoplasm.